Last update 08 Aug 2025

ALD-151

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms
ALDHbr umbilical cord blood cells, ALD 151
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
NeoplasmsHemic and Lymphatic DiseasesImmune System Diseases+ [3]
Active Indication-
Inactive Indication
Anemia, AplasticCongenital Bone Marrow Failure SyndromesHematologic Neoplasms+ [4]
Originator Organization
Nuo Therapeutics, Inc.Nuo Therapeutics, Inc.
Active Organization-
Inactive Organization
Aldagen, Inc.Aldagen, Inc.
Nuo Therapeutics, Inc.Nuo Therapeutics, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ALD-151
NCT00692926
/ CompletedPhase 1IIT
A Pilot Trial of Unrelated Umbilical Cord Blood Transplantation Augmented With Ex Vivo CytokinePrimed ALDHbr Umbilical Cord Blood Cells
100 Clinical Results associated with ALD-151
Login to view more data
100 Translational Medicine associated with ALD-151
Login to view more data
100 Patents (Medical) associated with ALD-151
Login to view more data
100 Deals associated with ALD-151
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
LeukemiaPhase 2-
Nuo Therapeutics, Inc.Nuo Therapeutics, Inc.
-
Anemia, AplasticPhase 1
United States
Aldagen, Inc.Aldagen, Inc.
01 Oct 2005
Congenital Bone Marrow Failure SyndromesPhase 1
United States
Aldagen, Inc.Aldagen, Inc.
01 Oct 2005
Metabolism, Inborn ErrorsPhase 1
United States
Aldagen, Inc.Aldagen, Inc.
01 Oct 2005
Myelodysplastic SyndromesPhase 1
United States
Aldagen, Inc.Aldagen, Inc.
01 Oct 2005
Primary Immunodeficiency DiseasesPhase 1
United States
Aldagen, Inc.Aldagen, Inc.
01 Oct 2005
Hematologic NeoplasmsPhase 1
United States
Aldagen, Inc.Aldagen, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free